vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and Perion Network Ltd. (PERI). Click either name above to swap in a different company.
Perion Network Ltd. is the larger business by last-quarter revenue ($368.7M vs $207.8M, roughly 1.8× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 2.1%, a 55.3% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $-2.9M).
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
Perion Network Ltd. is a publicly traded advertising technology company that provides digital advertising technology solutions to advertisers, agencies, retailers, and publishers. Its core offerings are delivered through Perion One, a unified omnichannel advertising platform designed to support campaign planning, activation, optimisation, and measurement across channels and verticals including connected television (CTV), digital out-of-home (DOOH), display, video advertising, as well as retai...
IDYA vs PERI — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $368.7M |
| Net Profit | $119.2M | $7.7M |
| Gross Margin | — | — |
| Operating Margin | 52.2% | 2.0% |
| Net Margin | 57.4% | 2.1% |
| Revenue YoY | — | — |
| Net Profit YoY | 330.1% | — |
| EPS (diluted) | $1.33 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $207.8M | $368.7M | ||
| Q2 25 | — | $266.5M | ||
| Q1 25 | — | $157.8M | ||
| Q3 24 | $0 | $508.9M | ||
| Q2 24 | $0 | $323.6M | ||
| Q1 24 | $0 | $145.2M | ||
| Q3 23 | — | $430.6M | ||
| Q2 23 | — | $272.0M |
| Q3 25 | $119.2M | $7.7M | ||
| Q2 25 | — | $5.6M | ||
| Q1 25 | — | $11.8M | ||
| Q3 24 | $-51.8M | $78.0M | ||
| Q2 24 | $-52.8M | $45.2M | ||
| Q1 24 | $-39.6M | $23.8M | ||
| Q3 23 | — | $60.5M | ||
| Q2 23 | — | $35.0M |
| Q3 25 | 52.2% | 2.0% | ||
| Q2 25 | — | -1.7% | ||
| Q1 25 | — | 5.4% | ||
| Q3 24 | — | 15.1% | ||
| Q2 24 | — | 13.7% | ||
| Q1 24 | — | 16.9% | ||
| Q3 23 | — | 15.8% | ||
| Q2 23 | — | 14.1% |
| Q3 25 | 57.4% | 2.1% | ||
| Q2 25 | — | 2.1% | ||
| Q1 25 | — | 7.5% | ||
| Q3 24 | — | 15.3% | ||
| Q2 24 | — | 14.0% | ||
| Q1 24 | — | 16.4% | ||
| Q3 23 | — | 14.1% | ||
| Q2 23 | — | 12.9% |
| Q3 25 | $1.33 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | $-0.60 | — | ||
| Q2 24 | $-0.68 | — | ||
| Q1 24 | $-0.53 | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $156.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $722.9M |
| Total Assets | $1.2B | $915.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $786.9M | $156.2M | ||
| Q2 25 | — | $156.2M | ||
| Q1 25 | — | $156.2M | ||
| Q3 24 | $920.0M | $187.6M | ||
| Q2 24 | $701.7M | $187.6M | ||
| Q1 24 | $698.8M | $187.6M | ||
| Q3 23 | — | $176.2M | ||
| Q2 23 | — | $411.2M |
| Q3 25 | $1.1B | $722.9M | ||
| Q2 25 | — | $722.9M | ||
| Q1 25 | — | $722.9M | ||
| Q3 24 | $1.2B | $718.1M | ||
| Q2 24 | $931.7M | $718.1M | ||
| Q1 24 | $935.3M | $718.1M | ||
| Q3 23 | — | $583.1M | ||
| Q2 23 | — | $636.5M |
| Q3 25 | $1.2B | $915.5M | ||
| Q2 25 | — | $915.5M | ||
| Q1 25 | — | $915.5M | ||
| Q3 24 | $1.2B | $1.1B | ||
| Q2 24 | $973.7M | $1.1B | ||
| Q1 24 | $961.5M | $1.1B | ||
| Q3 23 | — | $870.2M | ||
| Q2 23 | — | $903.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $2.6M |
| Free Cash FlowOCF − Capex | $142.2M | $-2.9M |
| FCF MarginFCF / Revenue | 68.4% | -0.8% |
| Capex IntensityCapex / Revenue | 0.0% | 1.5% |
| Cash ConversionOCF / Net Profit | 1.19× | 0.34× |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $142.2M | $2.6M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | $-49.2M | $105.2M | ||
| Q2 24 | $-32.9M | — | ||
| Q1 24 | $-43.8M | $17.8M | ||
| Q3 23 | — | $83.9M | ||
| Q2 23 | — | $49.3M |
| Q3 25 | $142.2M | $-2.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | $-49.7M | $104.7M | ||
| Q2 24 | $-33.9M | — | ||
| Q1 24 | $-45.1M | $17.6M | ||
| Q3 23 | — | $83.2M | ||
| Q2 23 | — | $48.8M |
| Q3 25 | 68.4% | -0.8% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | 20.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 12.2% | ||
| Q3 23 | — | 19.3% | ||
| Q2 23 | — | 18.0% |
| Q3 25 | 0.0% | 1.5% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.1% | ||
| Q3 23 | — | 0.2% | ||
| Q2 23 | — | 0.2% |
| Q3 25 | 1.19× | 0.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | 1.35× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.75× | ||
| Q3 23 | — | 1.39× | ||
| Q2 23 | — | 1.41× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IDYA
Segment breakdown not available.
PERI
| Advertising Solutions | $231.4M | 63% |
| Search Advertising | $137.3M | 37% |
